Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced Sep 13, 2026, 9:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 24 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Filters: Condition: Peripheral Access Clear all
Completed Not applicable Interventional

Comparison of Ultrasound Guided Peripheral IV Placement With and Without Use of a Guidewire

NCT02422472
View directory record Official record
Conditions
Difficult Peripheral IV Access
Interventions
Ultrasound guided peripheral IV placement
Device
Lead sponsor
Brigham and Women's Hospital
Other
Eligibility
18 Years and older
Enrollment
70 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2018
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Jan 15, 2019 · Synced Sep 13, 2026, 9:59 AM EDT
Completed Phase 2Phase 3 Interventional

VeinViewer for Peripheral IV Placement in Children With Difficult Intravenous (IV) Access

NCT00357799
View directory record Official record
Conditions
Catheterization, Peripheral, Phlebotomy
Interventions
VeinViewer
Device
Lead sponsor
Children's Hospital and Health System Foundation, Wisconsin
Other
Eligibility
Up to 19 Years
Enrollment
170 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2006 – 2010
U.S. locations
1
States / cities
Milwaukee, Wisconsin
Source: ClinicalTrials.gov public record
Updated Aug 23, 2011 · Synced Sep 13, 2026, 9:59 AM EDT
Completed No phase listed Observational

Use of Vein Viewer for Insertion of Peripheral Venous Cannula in Pediatric Patients With Difficult Intravenous Access

NCT00935909
View directory record Official record
Conditions
IV Cannulation
Interventions
Not listed
Lead sponsor
Peter Szmuk
Other
Eligibility
Up to 18 Years
Enrollment
603 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2010
U.S. locations
1
States / cities
Dallas, Texas
Source: ClinicalTrials.gov public record
Updated Jun 20, 2013 · Synced Sep 13, 2026, 9:59 AM EDT
Completed Not applicable Interventional

Single Lumen Midline Catheter vs Long Peripheral Intravenous Cather for Difficult Intravenous Access in the ED

NCT06668766
View directory record Official record
Conditions
Difficult Intravenous Access, Midline Catheter, Peripheral Intravenous Catheter, Emergency Department Patient
Interventions
10-cm Single Lumen Mildine, 4.78 cm Long Peripheral Intravenous Catheter
Device
Lead sponsor
Albany Medical College
Other
Eligibility
18 Years and older
Enrollment
270 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2026
U.S. locations
1
States / cities
Albany, New York
Source: ClinicalTrials.gov public record
Updated Aug 24, 2026 · Synced Sep 13, 2026, 9:59 AM EDT
Enrolling by invitation Not applicable Interventional

TruVascular Access - Ultrasound-Guided Vascular Access Study

NCT07798427
View directory record Official record
Conditions
Peripheral Venous Catheterization, Difficult Intravenous Access, Catheterization, Peripheral
Interventions
Ultrasound-Guided Peripheral Vascular Access, Standard Peripheral Vascular Access, Point-of-Care Ultrasound System for Vascular Access Guidance
Procedure · Device
Lead sponsor
Truway Health, Inc.
Industry
Eligibility
12 Years and older
Enrollment
250 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2030
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Aug 31, 2026 · Synced Sep 13, 2026, 9:59 AM EDT
Completed Not applicable Interventional Results available

Blood Sampling Functionality of Extended Dwell Catheters

NCT04409418
View directory record Official record
Conditions
IV Catheter-Related Infection or Complication, Vascular Access Complication, Peripheral Venous Access
Interventions
Extended dwell catheters
Device
Lead sponsor
Corewell Health East
Other
Eligibility
18 Years and older
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2023
U.S. locations
1
States / cities
Royal Oak, Michigan
Source: ClinicalTrials.gov public record
Updated Nov 14, 2024 · Synced Sep 13, 2026, 9:59 AM EDT
Recruiting Phase 2 Interventional

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

NCT00107289
View directory record Official record
Conditions
Neuroblastoma, Pheochromocytoma
Interventions
iobenguane I 131
Drug
Lead sponsor
Memorial Sloan Kettering Cancer Center
Other
Eligibility
1 Year and older
Enrollment
200 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2006 – 2027
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated May 28, 2026 · Synced Sep 13, 2026, 9:59 AM EDT
No Longer Available No phase listed Expanded access

An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT04825626
View directory record Official record
Conditions
Chronic Inflammatory Demyelinating Polyneuropathy
Interventions
HB-adMSCs
Biological
Lead sponsor
Hope Biosciences Research Foundation
Industry
Eligibility
Not listed
U.S. locations
1
States / cities
Sugar Land, Texas
Source: ClinicalTrials.gov public record
Updated Sep 28, 2025 · Synced Sep 13, 2026, 9:59 AM EDT
No Longer Available No phase listed Expanded access

Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

NCT01838187
View directory record Official record
Conditions
Neuroblastoma, Pheochromocytoma, Paraganglioma
Interventions
I-131 MIBG, Vorinostat
Radiation · Drug
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Other
Eligibility
12 Months and older
U.S. locations
1
States / cities
Cincinnati, Ohio
Source: ClinicalTrials.gov public record
Updated Aug 17, 2023 · Synced Sep 13, 2026, 9:59 AM EDT
Completed No phase listed Observational Results available

Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Intervention: REACH PVI

NCT03943160
View directory record Official record
Conditions
Peripheral Artery Disease
Interventions
Diamondback 360 Extended Length Orbital Atherectomy System
Device
Lead sponsor
Abbott Medical Devices
Industry
Eligibility
18 Years and older
Enrollment
50 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019
U.S. locations
6
States / cities
Phoenix, Arizona • Little Rock, Arkansas • Lafayette, Louisiana + 2 more
Source: ClinicalTrials.gov public record
Updated Jul 17, 2023 · Synced Sep 13, 2026, 9:59 AM EDT
Enrolling by invitation Not applicable Interventional Accepts healthy volunteers

Great Saphenous Vein Anatomy at the Proximal Medial Thigh as a Potential Site for Rescue Venous Access

NCT04922606
View directory record Official record
Conditions
Anatomy of the GSV for Rescue Peripheral IV Access
Interventions
US ot the GSV
Diagnostic Test
Lead sponsor
Mayo Clinic
Other
Eligibility
Not listed
Enrollment
190 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2021 – 2045
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Jul 19, 2026 · Synced Sep 13, 2026, 9:59 AM EDT
Completed No phase listed Observational

Percentage Venous Options in Pediatrics & Adults

NCT01453335
View directory record Official record
Conditions
Veins
Interventions
Not listed
Lead sponsor
Christie Medical Holdings, Inc.
Industry
Eligibility
Not listed
Enrollment
300 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011
U.S. locations
1
States / cities
Providence, Rhode Island
Source: ClinicalTrials.gov public record
Updated Dec 22, 2011 · Synced Sep 13, 2026, 9:59 AM EDT
Completed No phase listed Observational Accepts healthy volunteers

Screening and Access to Health Care for Vascular Disease

NCT01889485
View directory record Official record
Conditions
Aortic Aneurysm, Abdominal, Carotid Stenosis, Peripheral Arterial Disease
Interventions
Not listed
Lead sponsor
Endeavor Health
Other
Eligibility
55 Years and older
Enrollment
190 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2014 – 2021
U.S. locations
1
States / cities
Evanston, Illinois
Source: ClinicalTrials.gov public record
Updated Sep 27, 2023 · Synced Sep 13, 2026, 9:59 AM EDT
Completed Not applicable Interventional Results available

The Effect of Two Different Tourniquet Techniques on Peripheral IV Access Success Rates

NCT02389725
View directory record Official record
Conditions
Tourniquet
Interventions
disposable elastic tourniquet, blood pressure cuff
Device
Lead sponsor
Mayo Clinic
Other
Eligibility
18 Years and older
Enrollment
121 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2016
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated May 19, 2019 · Synced Sep 13, 2026, 9:59 AM EDT
Completed No phase listed Observational

BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study

NCT06632496
View directory record Official record
Conditions
BD Prevue II for Peripheral Intravenous Catheter Placement
Interventions
BD Prevue(TM) II
Device
Lead sponsor
Becton, Dickinson and Company
Industry
Eligibility
1 Year and older
Enrollment
156 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025
U.S. locations
2
States / cities
Brooklyn, New York • Pittsburgh, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Jan 15, 2026 · Synced Sep 13, 2026, 9:59 AM EDT
Completed No phase listed Observational Results available

Technique for Successful Ultrasound-guided Peripheral Vascular Access

NCT01975974
View directory record Official record
Conditions
Obesity, Vascular Diseases
Interventions
Ultrasound
Device
Lead sponsor
University of Iowa
Other
Eligibility
18 Years and older
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2015
U.S. locations
1
States / cities
Iowa City, Iowa
Source: ClinicalTrials.gov public record
Updated May 29, 2017 · Synced Sep 13, 2026, 9:59 AM EDT
No Longer Available No phase listed Expanded access

Expanded Access Protocol for Patients With Eosinophilic Esophagitis

NCT05095116
View directory record Official record
Conditions
Eosinophilic Esophagitis
Interventions
APT-1011 3 mg HS
Drug
Lead sponsor
Ellodi Pharmaceuticals, LP
Industry
Eligibility
12 Years and older
U.S. locations
35
States / cities
Tucson, Arizona • North Little Rock, Arkansas • Camarillo, California + 31 more
Source: ClinicalTrials.gov public record
Updated Oct 2, 2025 · Synced Sep 13, 2026, 9:59 AM EDT
Completed Not applicable Interventional Results available

Addressing Disparities in Neuromodulation for Rehabilitation: A Mixed Methods Approach to Optimize Access for Underrepresented Racial Minorities

NCT05896202
View directory record Official record
Conditions
Neuropathic Pain
Interventions
taVNS Video, Educational materials, TMS Video
Other
Lead sponsor
University of Miami
Other
Eligibility
18 Years to 80 Years
Enrollment
28 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024
U.S. locations
1
States / cities
Miami, Florida
Source: ClinicalTrials.gov public record
Updated Oct 26, 2025 · Synced Sep 13, 2026, 9:59 AM EDT
Recruiting Early Phase 1 Interventional

Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

NCT02356653
View directory record Official record
Conditions
Leukemia, Inborn Errors of Metabolism, Bone Marrow Failure Syndromes, Immunodeficiencies, Immunodysregulation Polyendocrinopathy Enteropathy X-linked Syndrome
Interventions
Transplant of stem cells with CD3+/CD19+ depletion (CliniMACs)
Biological
Lead sponsor
Children's Hospital of Philadelphia
Other
Eligibility
Up to 30 Years
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2030
U.S. locations
1
States / cities
Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Feb 19, 2026 · Synced Sep 13, 2026, 9:59 AM EDT
No Longer Available No phase listed Expanded access

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

NCT05064306
View directory record Official record
Conditions
Central Nervous System/Leptomeningeal Neoplasms
Interventions
131I-omburtamab
Drug
Lead sponsor
Memorial Sloan Kettering Cancer Center
Other
Eligibility
Not listed
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Jul 31, 2025 · Synced Sep 13, 2026, 9:59 AM EDT
Completed Not applicable Interventional Results available

Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)

NCT04283994
View directory record Official record
Conditions
Dementia, Chronic Disease, Neoplasm Metastasis, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive, Heart Failure, Congestive, Liver Cirrhosis, Kidney Failure, Chronic, Lung Diseases, Interstitial, Peripheral Vascular Disease, Diabetes With End Organ Injury
Interventions
Survey-based Patient/Clinician Jumpstart, EHR-based Clinician Jumpstart
Behavioral
Lead sponsor
University of Washington
Other
Eligibility
18 Years and older
Enrollment
756 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2025
U.S. locations
3
States / cities
Seattle, Washington
Source: ClinicalTrials.gov public record
Updated Jun 23, 2025 · Synced Sep 13, 2026, 9:59 AM EDT
Not listed Phase 1 Interventional

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

NCT00769613
View directory record Official record
Conditions
Cancer
Interventions
cytomegalovirus IE-1-specific cytotoxic T lymphocytes, cytomegalovirus pp65-specific cytotoxic T lymphocytes, therapeutic allogeneic lymphocytes, polymerase chain reaction, flow cytometry, immunological diagnostic method, laboratory biomarker analysis
Biological · Genetic · Other
Lead sponsor
Milton S. Hershey Medical Center
Other
Eligibility
2 Years and older
Enrollment
20 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
Started 2008
U.S. locations
1
States / cities
Hershey, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Dec 17, 2013 · Synced Sep 13, 2026, 9:59 AM EDT
Available No phase listed Expanded access

Expanded Access Protocol Using 131I-MIBG

NCT01590680
View directory record Official record
Conditions
Neuroblastoma, Pheochromocytoma, Paraganglioma
Interventions
I-131 MIBG
Radiation
Lead sponsor
Jubilant DraxImage Inc.
Industry
Eligibility
12 Months and older
U.S. locations
19
States / cities
Los Angeles, California • Aurora, Colorado • Atlanta, Georgia + 16 more
Source: ClinicalTrials.gov public record
Updated Feb 27, 2023 · Synced Sep 13, 2026, 9:59 AM EDT
Terminated Not applicable Interventional Accepts healthy volunteers Results available

A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children

NCT05204082
View directory record Official record
Conditions
Intravenous Access
Interventions
Single Use Vein Entry Indicator Device
Device
Lead sponsor
Mayo Clinic
Other
Eligibility
Up to 18 Years
Enrollment
169 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated May 22, 2024 · Synced Sep 13, 2026, 9:59 AM EDT